[Immunogenicity and reactogenicity of acellular pertussis vaccines intended for adolescent and adults]
[Article in
Polish]
Affiliations
- PMID: 22708307
Item in Clipboard
[Immunogenicity and reactogenicity of acellular pertussis vaccines intended for adolescent and adults]
[Article in
Polish]
Przegl Epidemiol.
2012.
Free article
Abstract
Although high immunization status against pertussis maintained in neonates and children, the increase in pertussis cases has been observed in Poland since 1990-ies, especially in adolescent and adults. Wide use of pertussis acellular vaccines intended for adolescents and adult's immunization might prolong immunity against pertussis. The goal of the work was to present current view of immunogenicity and reactogenicity of those pertussis vaccines in different age groups.
Similar articles
-
Effect of injection site on reactogenicity and immunogenicity of acellular and whole-cell pertussis component diphtheria-tetanus-pertussis vaccines in infants.Vaccine. 2005 Oct 17;23(43):5106-12. doi: 10.1016/j.vaccine.2005.05.039. Vaccine. 2005. PMID: 16023771
-
[Assessment of postvaccinal response in children past pertussis].Wiad Lek. 2006;59(11-12):819-22. Wiad Lek. 2006. PMID: 17427498 Polish.
-
Effectiveness of adolescent and adult tetanus, reduced-dose diphtheria, and acellular pertussis vaccine against pertussis.Clin Infect Dis. 2010 Aug 1;51(3):315-21. doi: 10.1086/653938. Clin Infect Dis. 2010. PMID: 20578875
-
Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): a review of evidences and recommendations.Vaccine. 2012 Jul 27;30(35):5179-90. doi: 10.1016/j.vaccine.2012.06.005. Epub 2012 Jun 15. Vaccine. 2012. PMID: 22709953 Review.
-
Update on adolescent immunization: review of pertussis and the efficacy, safety, and clinical use of vaccines that contain tetanus-diphtheria-acellular pertussis.J Pediatr Health Care. 2006 Jul-Aug;20(4):229-37. doi: 10.1016/j.pedhc.2005.12.011. J Pediatr Health Care. 2006. PMID: 16831630 Review.
